527
Participants
Start Date
December 11, 2019
Primary Completion Date
February 17, 2022
Study Completion Date
December 20, 2022
Secukinumab
The subjects will receive secukinumab 6 mg/kg i.v. at randomization (Baseline (BSL) visit), followed by the administration of secukinumab 3 mg/kg i.v. every four weeks starting at Week 4 through Week 48 (exposure through Week 52)
Placebo
The subjects will receive i.v. placebo at randomization (BSL visit), Weeks 4, 8, and 12 , followed by the administration of secukinumab 3 mg/kg i.v. at Week 16 and every four weeks through Week 48 (exposure through Week 52)
Novartis Investigative Site, Manila
Novartis Investigative Site, Brussels
Novartis Investigative Site, Quezon
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Leuven
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Dasmariñas
Novartis Investigative Site, Lipa City
Novartis Investigative Site, Pleven
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkoknoi
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Duncansville
Novartis Investigative Site, Cumberland
Novartis Investigative Site, Beckley
Novartis Investigative Site, Pátrai
Novartis Investigative Site, Greensboro
Novartis Investigative Site, Columbia
Novartis Investigative Site, Ipoh
Novartis Investigative Site, Winter Park
Novartis Investigative Site, Plantation
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Ocoee
Novartis Investigative Site, Verona
Novartis Investigative Site, Memphis
Novartis Investigative Site, Jackson
Novartis Investigative Site, Khon Kaen
Novartis Investigative Site, Bowling Green
Novartis Investigative Site, Middleburg Heights
Novartis Investigative Site, Grand Blanc
Novartis Investigative Site, Siena
Novartis Investigative Site, Kuala Lumpur
Novartis Investigative Site, Gwangju
Novartis Investigative Site, Selangor Darul Ehsan
Novartis Investigative Site, Lincoln
Novartis Investigative Site, Seremban
Novartis Investigative Site, The Woodlands
Novartis Investigative Site, Spring
Novartis Investigative Site, Katy
Novartis Investigative Site, Songkhla
Novartis Investigative Site, Upland
Novartis Investigative Site, La Mesa
Novartis Investigative Site, Irvine
Novartis Investigative Site, Kuching
Novartis Investigative Site, San Leandro
Novartis Investigative Site, Portland
Novartis Investigative Site, Everett
Novartis Investigative Site, Spokane
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Cundinamarca
Novartis Investigative Site, Moscow
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Petrozavodsk
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Surat
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Ulyanovsk
Novartis Investigative Site, Chelyabinsk
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Yekaterinburg
Novartis Investigative Site, Novosibirsk
Novartis Investigative Site, Novosibirsk
Novartis Investigative Site, Kemerovo
Novartis Investigative Site, Kemerovo
Novartis Investigative Site, Ibagué
Novartis Investigative Site, Vitória
Novartis Investigative Site, Salvador
Novartis Investigative Site, Juiz de Fora
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, São José do Rio Preto
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Bucaramanga
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Ostrava
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Uherské Hradiště
Novartis Investigative Site, Athens
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Bangalore
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Nashik
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Krakow
Novartis Investigative Site, Sochaczew
Novartis Investigative Site, Torun
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Danderyd
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Adana
Novartis Investigative Site, Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY